Transactions:
TSN Info
Search:
Information contained within the links below is distributed by companies featured through PR Newswire.  Neither The Sports Network nor PR Newswire is responsible for the content.

Clinical Trials & Medical Discoveries Headlines from PR Newswire


< Go Back

First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams
Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support
PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756
Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting
Clinical trial tests targeting prostate cancer treatment
First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection
Intensified, Liposomal Anthracycline-Based Chemo Regimen for Children with Leukemia May Offer High Survival Rates Without Added Heart Toxicity
Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain
Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results
Smile Perfected 20 Minute Whitening System Supports the American Dental Association's Preference of Dental Supervision During Treatments
Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference
Aeterna Zentaris: Posters to be Presented on Phase 1 and Phase 2 Trials with AEZS-108 in Prostate and Breast Cancer at Upcoming ASCO Meeting
Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease
Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference
OncoGenex Announces Plans for the Initiation of the Cedar™ Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Squamous Cell Lung Cancer
InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013
Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers
Prometheus Laboratories Presents New Data On Growing IBD Diagnostic Portfolio At Digestive Disease Week 2013
The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients
New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR
First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System
New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System
Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial
Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance
Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures
Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data
Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency
Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer
Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye
iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza
Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma Trial
OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting
Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System
Changing Cancer's Environment To Halt Its Spread
LipiGesic® M Migraine Treatment Product Shown to be as Effective as Prescription Based Medications
Study Finds Vitamin C Can Kill Drug-Resistant TB
Boston Scientific Long Term Data Demonstrate Bronchial Thermoplasty Treatment Benefits Persist Out to Five Years in Patients with Severe Asthma
ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials
Maryland Stem Cell Research Commission Funds 31 New Research Proposals in FY 2013
New Data Validates CyberKnife SBRT for Prostate Cancer Treatment
Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
Boehringer Ingelheim Presents Phase 3 Sub-Analyses for Tiotropium Across a Range of Symptomatic Asthma Patients at ATS 2013
Benvenue Medical Completes Follow-Up Phase in KAST Study Evaluating Kiva® VCF Treatment System vs. Balloon Kyphoplasty
Coffee Consumption Associated With Reduced Risk Of Autoimmune Liver Disease
Vitamin D Supplements May Help Relieve Symptoms Related To Crohn's

< Prev Next >
PR Newswire - United Business Media